Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday's close of $54.35. The intraday move extends what has already been a powerful 2026 ...
Pfizer (NYSE:PFE | PFE Price Prediction) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push ...
Hosted on MSN
Moderna stock is up 6% today: Is it outperforming other vaccine stocks like Pfizer and Novavax?
Moderna (MRNA) stock surged on renewed Hantavirus vaccine interest following a cruise ship outbreak, with Q1 revenue beating consensus at $389M versus $236M expected, driven by $311M in international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results